Showing results (561-570 of 877) with videos related to

Sort By:
Pageof 88
British Journal of Haematology|August 16, 2005
Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphomaC Burton, P Smith, G Vaughan-Hudson, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 1, 1994
An animal model of visual loss from orbital hemorrhageD G Schabdach, S H Goldberg, M E Breton, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Adenine nucleotide binding sites on beef heart F1 ATPase: photoaffinity labeling of beta-subunit Tyr-368 at a noncatalytic site and beta Tyr-345 at a catalytic siteR L Cross, D Cunningham, C G Miller, et al.
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.
American Journal of Public Health|September 29, 2007
Use of geographic information systems for planning HIV prevention interventions for high-risk youthsCatherine G Geanuracos, Shayna D Cunningham, George Weiss, et al.
The Journal of Chemical Physics|August 10, 2017
Optical determination of the electronic coupling and intercalation geometry of thiazole orange homodimer in DNAPaul D Cunningham, William P Bricker, Sebastián A Díaz, et al.
Oncology|December 15, 2010
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancerA F C Okines, U Asghar, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Unknown primary carcinoma: randomised studies are needed to identify optimal treatments and their benefitsD C Farrugia, A R Norman, M C Nicolson, et al.
Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancerM Findlay, A Hill, D Cunningham, et al.
Pageof 88